You are here

Award Data

For best search results, use the search terms first and then apply the filters

The Award database is continually updated throughout the year. As a result, data for FY21 is not expected to be complete until September, 2022.

Download all award data either with award abstracts (290MB) or without award abstracts (65MB). A data dictionary and additional information is located on the Data Resource Page. Files are refreshed monthly.

  1. Donaldson Decompression Needle for automated diagnosis and treatment of tension pneumothorax

    SBC: Critical Innovations LLC            Topic: DHA191007

    The Defense Health Agency seeks to develop a universal, automated needle decompression device to more effectively manage tension pneumothorax on the battlefield. Critical Innovations, KARA & Associates, and the Ross Lab at OHSU, with consultants Captain David Tanen MD, FAAEM, FACMT (USN, Ret.) and Commander Denise Whitfield, MD, FACEP (USN, Ret.), have formed a team of medical device experts to ad ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  2. Human Cell-Based Biosensor (HCB)

    SBC: SPZ TECHNOLOGIE LLC            Topic: DHA191006

    To address the US Army need in novel toxicity sensing methods using a platform compatible with the Environmental Sentinel Biomonitor (ESB) for testing Army field water with the goal of increasing toxicant sensitivity and reducing consumable size and cost, SPZ Technologies, LLC (SPZT) proposes to continue the development a Human Cell-Based Biosensor (HCB). The HCB is based on novel human cells lyop ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  3. Development of the MagAid for Simplified Pain Management During Prolonged Field Care Using Pulsed Magnetic Fields

    SBC: Luna Innovations Incorporated            Topic: DHA191011

    Over 50,000 American warfighters had been wounded in action in Operations Iraqi and Enduring Freedom with over 1,500 requiring major limb amputations. Warfighters and first responders must have proper tools for pain management during prolonged field care, allowing rapid stabilization and extraction while mitigating chronic pain effects. Recent studies indicate that magnetic fields can produce temp ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  4. Succor Combat Foam for Large Burn Wounds

    SBC: Critical Innovations LLC            Topic: DHA201D001

    The Defense Health Agency seeks to develop a novel field-expedient, antimicrobial, anti-biofilm, hydrogel wound dressing for acute care of large burn wounds for use at the point of injury, thru medical evacuation, and during prolonged field care. Critical Innovations, KARA & Associates, the Ross Lab at OHSU, and Toxikon, with consultants Captain David Tanen, MD, FAAEM, FACMT (USN, Rt.) and former ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  5. Deployable Wound Care Products to Decrease Preventable Death Outcomes by Mitigating Infection on Battlefield and through Long Term Care

    SBC: KERICURE INC.            Topic: DHA201D001

    One of the greatest threats to an injured warfighter is infection. Exposure to dangerous pathogens carries a life-threatening risk, but it can also have severe morbidity consequences including sepsis, amputation, lengthy hospital stays and years of battling the infection. Field injuries are especially at risk, where dirt, shreds of the soldier’s clothing and other debris can infiltrate the wound ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  6. Phase II Follow-on for the Medic's Enahnced Diagnostic Imaging Companion (MEDIC Phase II)

    SBC: Augmntr, Inc.            Topic: DHA191001

    Augmntr had a highly successful Phase I effort on MEDIC, demonstrating a full proof-of-concept system. In Phase II, Augmntr will build upon that, working toward a system capable of being used by medics and utilizing the more appropriate hardware available. The key work includes building upon the Avatar, Body Tracking and User Interface work performed in Phase I, while tracking emerging headset har ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  7. Rapid Portable ID and AST Diagnostic for Infected Wound Infections

    SBC: GeneCapture, Inc.            Topic: DHA201001

    GeneCapture is proposing to use its rapid CAPTURE assay (Confirm Active Pathogens Through Unamplified RNA Expression) to identify the pathogen(s) in wound infections. The pathogen Infection Diagnostic (ID)test takes place in a disposable cartridge that integrates and automates the sample prep steps and determines the genetic signature of the pathogens present. The assay is based on immobilized ste ...

    SBIR Phase I 2020 Department of DefenseDefense Health Agency
  8. Development of an Effective Adsorber to Remove Anti-A and Anti-B Antibodies from Plasma for Transfusion

    SBC: CYTOSORBENTS MEDICAL INC            Topic: DHP15B001

    Over 2.7 million units of plasma are transfused annually in the United States mainly to treat trauma, shock, burn injury, and emergency surgery. Plasma from AB individuals, often referred to as universal plasma, is in high demand for both military and civilian emergency transfusions as it does not contain anti-A and anti-B antibodies that could induce fatal hemolytic reactions as a result of their ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  9. Advanced Female Trauma Training System

    SBC: VCOM3D INC            Topic: DHP16002

    For this PhaseII SBIR, Vcom3D,with its subcontractors, the University of Washington and IVIR, Inc.,will develop an Advanced Female Trauma Training System (AFTTS) with realisticfemale anatomy, physiology, and behaviors. The AFTTS include both a Female Trauma Manikin and a tablet-based Virtual Instructor/Patient System (VIPS) thatcommunicates wirelessly with themanikin. The AFTTSwill includesensors ...

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
  10. Real-Time Small-Volume Blood Sampling and Analysis for Coagulopathy of Trauma Analytes

    SBC: Aptitude Medical Systems, Inc.            Topic: DHP15012

    Traumatic hemorrhage is the primary mechanism of death in potentially survivable combat injuries, and is the leading cause of death for civilians under the age of 44. A major underlying cause of this high mortality is Acute Traumatic Coagulopathy, a deadl

    SBIR Phase II 2020 Department of DefenseDefense Health Agency
US Flag An Official Website of the United States Government